The clinical significance of fibrinogen degradation products.
D001778:Blood Coagulation Disorders / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D001808:Blood Vessels / Q000033:anatomy & histology / Q000503:physiopathology; D002315:Cardiopulmonary Bypass; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000150:complications / Q000503:physiopathology; D005260:Female; D005337:Fibrin / Q000096:biosynthesis; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis* / Q000502:physiology; D005342:Fibrinolysis; D006801:Humans; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000097:blood / Q000209:etiology / Q000503:physiopathology; D009203:Myocardial Infarction / Q000097:blood; D009369:Neoplasms / Q000097:blood / Q000150:complications; D011247:Pregnancy; D011655:Pulmonary Embolism / Q000097:blood; D013577:Syndrome; D013917:Thrombin / Q000096:biosynthesis; D013924:Thrombophlebitis / Q000097:blood; D013927:Thrombosis / Q000097:blood / Q000175:diagnosis
D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; D005337:Fibrin; D013917:Thrombin